Synthesis and pharmacological characterization of 5-phenyl-2-[2-(1-piperidinylcarbonyl)phenyl]-2,3-dihydro-1H-pyr rolo[1,2-c]imidazol-1-ones: A new class of Neuropeptide S antagonists

A new class of selective NPS antagonist was developed starting from a commercially available product identified by screening activities. Experimental NMR observations and computational experiments allowed the discovery of a new class of derivatives. 5-Phenyl-2-[2-(1-piperidinylcarbonyl)phenyl]-2,3-d...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry letters Vol. 20; no. 24; pp. 7308 - 7311
Main Authors Micheli, Fabrizio, Di Fabio, Romano, Giacometti, Angelo, Roth, Adelheid, Moro, Elisa, Merlo, Giancarlo, Paio, Alfredo, Merlo-Pich, Emilio, Tomelleri, Silvia, Tonelli, Federica, Zarantonello, Paola, Zonzini, Laura, Capelli, Anna Maria
Format Journal Article
LanguageEnglish
Published 15.12.2010
Online AccessGet full text

Cover

More Information
Summary:A new class of selective NPS antagonist was developed starting from a commercially available product identified by screening activities. Experimental NMR observations and computational experiments allowed the discovery of a new class of derivatives. 5-Phenyl-2-[2-(1-piperidinylcarbonyl)phenyl]-2,3-dihydro-1H-pyr rolo[1,2-c]imidazol-1-one represents a new lead compound in the NPS antagonist field.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Feature-1
ISSN:0960-894X
DOI:10.1016/j.bmcl.2010.10.067